PUBLIC CONTRACT · 2018
Medicamento Vedolizumab 300 mg Pó conc sol inj Fr IV
- Contract value
- €81,361.36
- Signed on
- 8 March 2018
- Procedure
- Direct award, general (Ajuste Direto Regime Geral)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 5077068PUBLISHED DESCRIPTION
61 906 2018 Medicamento Vedolizumab 300 mg Pó conc sol inj Fr IV
Parties involved
- Place of performance
- Portugal, Faro, Faro
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- TAKEDA - FARMACEUTICA PORTUGAL, LDA · Tax ID 502801204
Values and timeline
- Contract price
- €81,361.36
- Procedure base price
- €0.00
- Total effective price
- Not reported on Portal BASE
- Publication date
- 28 December 2018
- Award date
- 31 January 2018
- Signing date
- 8 March 2018
- Performance period
- 334 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Direct award, general (Ajuste Direto Regime Geral)
- Award criterion
- Not stated
- CPV code
- 33690000-3 - Medicamentos vários
- Legal basis
- Artigo 24.º, n.º 1, alínea e), subalínea iii) do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos ( DL 111-B/2017 )
- Framework agreement
- Not stated
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 3230803
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.